$FMHS
FARMHOUSE, INC. /NV

2022 Q3 Form 10-Q Financial Statement

#000109690622002040 Filed on August 29, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $4.974K $2.649K $0.00
YoY Change 3216.0% 385.16% -100.0%
Cost Of Revenue $2.487K $0.00 $0.00
YoY Change -100.0%
Gross Profit $2.487K $2.649K $0.00
YoY Change 1569.13% 385.16% -100.0%
Gross Profit Margin 50.0% 100.0%
Selling, General & Admin $176.9K $249.4K $218.3K
YoY Change -28.75% 1.82% 64.81%
% of Gross Profit 7114.19% 9414.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $90.00
YoY Change -100.0% -100.0% -70.0%
% of Gross Profit 0.0% 0.0%
Operating Expenses $176.9K $249.4K $218.4K
YoY Change -28.84% 1.7% 64.5%
Operating Profit -$174.4K -$246.7K -$218.4K
YoY Change -29.8% 0.84% 68.76%
Interest Expense $15.63K $9.336K -$15.81K
YoY Change -221.69% -18.71% 99.87%
% of Operating Profit
Other Income/Expense, Net $149.4K -$9.336K -$15.81K
YoY Change 567.45% -18.71%
Pretax Income -$25.07K -$256.1K -$234.2K
YoY Change -88.84% -0.04% 70.55%
Income Tax
% Of Pretax Income
Net Earnings -$25.07K -$256.1K -$234.2K
YoY Change -88.84% -0.03% 70.56%
Net Earnings / Revenue -503.98% -9667.01%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$16.11K -$14.87K
COMMON SHARES
Basic Shares Outstanding 16.98M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $116.1K $0.00 $830.00
YoY Change 158.08% -100.0%
Cash & Equivalents $116.1K $0.00 $830.00
Short-Term Investments
Other Short-Term Assets $7.620K $3.810K $7.620K
YoY Change 1213.79% 63.52%
Inventory
Prepaid Expenses $7.620K $3.810K
Receivables $4.974K
Other Receivables $0.00
Total Short-Term Assets $128.7K $3.810K $8.450K
YoY Change 182.44% -51.59%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $250.00 $250.00 $250.00
YoY Change -37.5% -63.24%
TOTAL ASSETS
Total Short-Term Assets $128.7K $3.810K $8.450K
Total Long-Term Assets $250.00 $250.00 $250.00
Total Assets $129.0K $4.060K $8.700K
YoY Change 180.53% -52.51% 787.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.855K $19.79K $9.050K
YoY Change -69.56% 7.17% -70.43%
Accrued Expenses $144.1K $137.1K $1.389M
YoY Change -87.17% -87.17% 38.97%
Deferred Revenue
YoY Change
Short-Term Debt $320.0K $127.7K $127.7K
YoY Change 204.76% 34.37% 183.67%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.842M $1.766M $1.684M
YoY Change 31.35% 30.19% 36.02%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.842M $1.766M $1.684M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.842M $1.766M $1.684M
YoY Change 31.35% 30.19% 36.02%
SHAREHOLDERS EQUITY
Retained Earnings -$5.817M -$5.792M
YoY Change
Common Stock $1.703K $1.596K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.713M -$1.762M -$1.675M
YoY Change
Total Liabilities & Shareholders Equity $129.0K $4.060K $8.700K
YoY Change 180.53% -52.51% 787.76%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$25.07K -$256.1K -$234.2K
YoY Change -88.84% -0.03% 70.56%
Depreciation, Depletion And Amortization $0.00 $0.00 $90.00
YoY Change -100.0% -100.0% -70.0%
Cash From Operating Activities -$174.2K -$22.74K -$45.66K
YoY Change 161.31% -71.26% 455.47%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $165.0K $0.00 $0.00
YoY Change
Cash From Investing Activities $165.0K $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 125.4K 21.91K 42.71K
YoY Change 18.11% -74.12% 890.95%
NET CHANGE
Cash From Operating Activities -174.2K -22.74K -45.66K
Cash From Investing Activities 165.0K 0.000 0.000
Cash From Financing Activities 125.4K 21.91K 42.71K
Net Change In Cash 116.1K -830.0 -2.950K
YoY Change 194.27% -114.98% -24.55%
FREE CASH FLOW
Cash From Operating Activities -$174.2K -$22.74K -$45.66K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity File Number
EntityFileNumber
333-238326
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3321759
dei Entity Address Address Line1
EntityAddressAddressLine1
548 Market Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 90355
dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94104
dei Entity Address Address Description
EntityAddressAddressDescription
Address of Principal Executive Office
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
420-6856
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16979950 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3780 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3810 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3750 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
3810 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
7530 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
94 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
250 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
250 usd
CY2022Q2 us-gaap Assets
Assets
4060 usd
CY2021Q4 us-gaap Assets
Assets
7874 usd
CY2022Q2 us-gaap Bank Overdrafts
BankOverdrafts
158 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
19794 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9500 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
427322 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
391067 usd
CY2022Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
853536 usd
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
761463 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
137050 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
100796 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
44470 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
38070 usd
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
45000 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
45000 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
82650 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
75030 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
155780 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
158191 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1765602 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1579117 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
295000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
295000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15957950 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15957950 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15694550 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15694550 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1596 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1570 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4029075 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3729104 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5792213 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5301917 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1761542 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1571243 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4060 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7874 usd
CY2022Q2 us-gaap Revenues
Revenues
2649 usd
CY2021Q2 us-gaap Revenues
Revenues
546 usd
us-gaap Revenues
Revenues
2649 usd
us-gaap Revenues
Revenues
11896 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
2649 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
546 usd
us-gaap Gross Profit
GrossProfit
2649 usd
us-gaap Gross Profit
GrossProfit
11896 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
121328 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
120623 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
213914 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
193971 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
128064 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
124310 usd
us-gaap Professional Fees
ProfessionalFees
253793 usd
us-gaap Professional Fees
ProfessionalFees
191436 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
295 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
94 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
589 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
249392 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
245228 usd
us-gaap Operating Expenses
OperatingExpenses
467801 usd
us-gaap Operating Expenses
OperatingExpenses
385996 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-246743 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-244682 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-465152 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-374100 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
9336 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
11485 usd
us-gaap Interest Expense
InterestExpense
25144 usd
us-gaap Interest Expense
InterestExpense
19392 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9336 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11485 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-25144 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19392 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-256079 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-256167 usd
us-gaap Net Income Loss
NetIncomeLoss
-490296 usd
us-gaap Net Income Loss
NetIncomeLoss
-393492 usd
CY2022Q2 fil Basic And Diluted Net Loss Per Share
BasicAndDilutedNetLossPerShare
-0.02
CY2021Q2 fil Basic And Diluted Net Loss Per Share
BasicAndDilutedNetLossPerShare
-0.02
fil Basic And Diluted Net Loss Per Share
BasicAndDilutedNetLossPerShare
-0.03
fil Basic And Diluted Net Loss Per Share
BasicAndDilutedNetLossPerShare
-0.03
CY2022Q2 fil Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
15892784 shares
CY2021Q2 fil Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
14998382 shares
fil Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
15905636 shares
fil Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
14938674 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1571243 usd
CY2022Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
35105 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
69412 usd
CY2022Q1 fil Stock Based Compensation On Rsa S Vested
StockBasedCompensationOnRsaSVested
25500 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-234217 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1675443 usd
CY2022Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
24310 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
120170 usd
CY2022Q2 fil Stock Based Compensation On Rsa S Vested
StockBasedCompensationOnRsaSVested
25500 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-256079 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1761542 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1135712 usd
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
6000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
29868 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-137325 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1237169 usd
CY2021Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
25000 usd
CY2021Q2 fil Common Stock Issued For Anti Dilution Protection
CommonStockIssuedForAntiDilutionProtection
0 usd
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
120713 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-256167 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1347623 usd
us-gaap Net Income Loss
NetIncomeLoss
-490296 usd
us-gaap Net Income Loss
NetIncomeLoss
-393492 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
94 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
589 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
189582 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
150581 usd
fil Stock Based Compensation On Rsa S Vested
StockBasedCompensationOnRsaSVested
51000 usd
fil Stock Based Compensation On Rsa S Vested
StockBasedCompensationOnRsaSVested
0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
60 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2332 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10294 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7496 usd
us-gaap Legal Fees
LegalFees
36255 usd
us-gaap Legal Fees
LegalFees
20940 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
92073 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
92070 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
36254 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
19228 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
6400 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
4139 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-68404 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-103781 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
59415 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
31000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
7620 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
50000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
29436 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2411 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
5023 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
64624 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
105413 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3780 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1632 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3780 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3906 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5538 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
0 usd
us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
0 usd
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0 usd
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
2292 usd
fil Common Stock Issued For Anti Dilution Protection
CommonStockIssuedForAntiDilutionProtection
0 usd
fil Common Stock Issued For Anti Dilution Protection
CommonStockIssuedForAntiDilutionProtection
4 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font:11pt Times New Roman;margin:0;margin-right:-1.8pt"> </p> <p style="font:11pt Times New Roman;margin:0;text-indent:36pt"><b><i>Organization</i></b></p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">The Company was incorporated in June 2013 as Somerset Transition Corporation under the Oklahoma General Corporation Act. The Company was formed to complete a reorganization under Section 1088(g) of the Oklahoma Act, whereby the Company became successor to Transnational Financial Network, Inc., which was originally incorporated in California in 1985. In September 2013, the Company was redomesticated in Maryland and changed its name to Somerset Property, Inc. In July 2017, the Company was redomesticated in Nevada and changed its name to Revival, Inc. In June 2019, the Company changed its name to Farmhouse, Inc. to reflect its new business endeavors. </p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">In August 2019, the Company acquired Farmhouse, Inc., a Washington corporation (“Farmhouse Washington”) as its wholly owned subsidiary (the “Acquisition”). Farmhouse Washington was formed in January 2014 and has developed a social network platform, “The WeedClub® Platform”. At the closing of the Acquisition, all of the issued and outstanding shares of common stock of Farmhouse Washington were exchanged for shares of common stock of the Company on a one-for-one basis. The financial statements of the Company are the continuation of Farmhouse Washington with the adjustment to reflect the capital structure of the Company. </p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">Prior to the Acquisition, in August 2017, Farmhouse Washington formed Farmhouse DTLA, Inc. (“DTLA”) in California as a wholly owned subsidiary. On April 8, 2021, DTLA was awarded a 49% equity interest in a Los Angeles based multi-licensed cannabis retail dispensary, grow, manufacturer and distributor called Los Angeles Farmers, Inc. (“LAFI”). Although ownership percentages over 20% would typically be accounted for using the equity method, the Company is accounting for this investment as an investment in equity securities due to the Company not having significant influence over LAFI. The cost of this investment was expensed during the fiscal year ended December 31, 2017 and, due to uncertainties surrounding the value of LAFI and determining any award of back profits and interest, as well as the pending litigation, no value has been reflected in our unaudited interim condensed consolidated financial statements as of June 30, 2022. See Note 9.</p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0;text-indent:36pt"><b><i>Current Operations</i></b></p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">The Company is a technology company with multiple cannabis related divisions and IP, including the WeedClub® Platform, a professional social network platform to the regulated cannabis industry, which enables cannabis and hemp professionals to connect, discover products and services and scale their businesses. Within the WeedClub® Platform, members utilize an increasing set of technology-based tools for discovering professional connections and information. The Company believes it has established itself as the trusted brand to connect the industry through the WeedClub® Platform and its @420 Twitter handle. The Company offers its WeedClub members group opportunities while advertising and consulting revenues are generated via the curated opportunities.</p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0;text-indent:36pt"><b><i>Going Concern and Management’s Plans</i></b></p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">The accompanying unaudited interim condensed consolidated financial statements have been presented on the basis that the Company is a going concern which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. For the six months ended June 30, 2022, the Company had a net loss from operations of $465,152, consisting primarily of general and administrative </p> <p style="font:11pt Times New Roman;margin:0">and legal and professional expenses. In addition, as of June 30, 2022, the Company had stockholders’ deficit of $1,761,542 and available cash on hand of zero. In view of these matters, recoverability of any asset amounts shown in the accompanying unaudited interim condensed consolidated financial statements is dependent upon the Company’s ability to expand operations and achieve profitability from its business. These factors raise substantial doubt about the Company’s ability to continue as a going concern. These unaudited interim condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">The Company has financed its activities principally from the sale of its common stock and loans from Company officers. The Company intends on financing its future working capital needs from these sources until such time that funds provided by operations are sufficient to fund working capital requirements. Management believes that loans from Company officers and funds raised from the sale of its common stock will allow sufficient capital for operations and to continue as a going concern.</p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">On February 1, 2022, the board of directors (“Board”) authorized an offering of up to 294,118 shares of restricted common stock at $0.85 per share, providing proceeds of up to $250,000, to be offered and sold only to investors that qualify as “accredited investors” as that term is defined in Regulation D. For the six months ended June 30, 2022, the Company sold 69,900 shares of common stock under this offering for proceeds of $59,415. The offering expired on August 1, 2022. See Note 7.</p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">Subsequent to June 30, 2022, the Company received cash proceeds totaling $390,000, including $225,000 of funding under a Litigation Funding Agreement and $165,000 of proceeds from the sale of its domain name “blunt.com.” See Note 12.</p>
us-gaap Operating Income Loss
OperatingIncomeLoss
-465152 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1761542 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font:11pt Times New Roman;margin:0;text-indent:36pt"><b><i>Financial Statement Reclassification</i></b></p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0">Certain amounts from the prior year’s financial statements have been reclassified in these unaudited interim condensed consolidated financial statements to conform to the current year’s classifications.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font:11pt Times New Roman;margin:0;text-indent:36pt"><b><i>Use of Estimates</i></b></p> <p style="font:11pt Times New Roman;margin:0"> </p> <p style="font:11pt Times New Roman;margin:0;color:#000000">Operating results for interim periods are not necessarily indicative of the results to be expected for the full year. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Significant estimates include the carrying value of property and equipment and intangible assets, grant date fair value of options, deferred tax assets and any related valuation allowance and related disclosure of contingent assets and liabilities. The Company evaluates its estimates, based on historical experience and on various other assumptions that it believes to be reasonable under the circumstances. Actual results could materially differ from these estimates.</p>
CY2022Q2 us-gaap Revenues
Revenues
2649 usd
CY2021Q2 us-gaap Revenues
Revenues
546 usd
us-gaap Revenues
Revenues
2649 usd
us-gaap Revenues
Revenues
11896 usd
us-gaap Cost Of Revenue
CostOfRevenue
8000 usd
CY2022Q2 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
7312 usd
CY2021Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
7312 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7312 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7218 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
94 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
94 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
589 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
94 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
45000 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
82650 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
75030 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
155780 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
158191 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2411 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
5023 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
295000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
295000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
59415 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
189582 usd
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15957950 shares
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
6000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
150581 usd
CY2021Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
25000 usd
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15131656 shares
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
150000 shares
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.02
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
50000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.02
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
100000 shares
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.02
fil Stock Based Compensation On Rsa S Vested
StockBasedCompensationOnRsaSVested
51000 usd
CY2022Q2 fil Unrecognized Stock Based Compensation On Rsa S Vested
UnrecognizedStockBasedCompensationOnRsaSVested
102000 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
155780 usd
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
158191 usd
fil Stock Based Compensation On Rsa S Vested
StockBasedCompensationOnRsaSVested
51000 usd
CY2022Q2 fil Unrecognized Stock Based Compensation On Rsa S Vested
UnrecognizedStockBasedCompensationOnRsaSVested
102000 usd

Files In Submission

Name View Source Status
0001096906-22-002040-index-headers.html Edgar Link pending
0001096906-22-002040-index.html Edgar Link pending
0001096906-22-002040.txt Edgar Link pending
0001096906-22-002040-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fmhs-20220630.htm Edgar Link pending
fmhs-20220630.xsd Edgar Link pending
fmhs-20220630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
fmhs-20220630_cal.xml Edgar Link unprocessable
fmhs-20220630_htm.xml Edgar Link completed
fmhs-20220630_pre.xml Edgar Link unprocessable
fmhs-20220630_lab.xml Edgar Link unprocessable
fmhs_ex31z1.htm Edgar Link pending
fmhs_ex31z2.htm Edgar Link pending
fmhs_ex32z1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending